Navigation Links
Lupus Under the Spotlight: U.S. Congress Shows Support for Women's Health Issues
Date:5/12/2008

dically underserved portion of America's population. It is vital that American women are aware of diseases more common in women, take care of their health, and talk to their doctors about symptoms that might be part of a more serious condition," says ALR's Scientific Advisory Board Chair, Dr. Mary K. Crow. "Lupus can cause heart and kidney disease - two leading causes of death for women - so we are grateful to our Members of Congress for shining a light on this important issue."

The Alliance for Lupus Research (ALR) is a national voluntary health organization based in New York City and founded in 1999. Chaired by Robert Wood Johnson IV, it has become the world's largest private source of lupus research funds and has committed $50 million to lupus-specific research projects since its inception. The organization's mission is to find better treatments and ultimately prevent and cure lupus by supporting medical research. Because the ALR's Board of Directors pays for all administrative and fundraising costs, 100% of all donations go directly to support lupus research programs. For more information, visit http://www.lupusresearch.org.


'/>"/>
SOURCE Alliance for Lupus Research
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine technology :

1. Statement From the Lupus Foundation of America Regarding the Release of Top-Line Results From a Study of Rituxan for the Treatment of Lupus
2. Rigels R788 Slows Progression of Murine Lupus in Preclinical Studies
3. Steps Toward Stopping Autoimmune Disease: International Consortium Identifies Genes Linked to Lupus
4. Tolerx Achieves Milestone with Completion of Phase Ib Clinical Study of TRX1 in Cutaneous Lupus Erythematosus
5. Human Genome Sciences Reports Positive Data from Long-Term Treatment with LymphoStat-B(R) in Patients with Active Systemic Lupus Erythematosus
6. Coley Pharmaceutical Group Diversifies Pipeline with First-in-Class TLR Antagonist for the Treatment of Systemic Lupus Erythematosus
7. New Risk Gene for Rheumatoid Arthritis and Lupus Opens Door to More Effective Treatments
8. Arena Pharmaceuticals, Inc. Announces Initiation of Phase 1 Clinical Trial of Drug Candidate Under Partnership with Taisho Pharmaceutical Co., Ltd.
9. Aida Announces New Anti-Cancer Drug Under Development
10. Michael J. Fox Foundation Commits up to $10 Million for Pre-Clinical Drug Development Under Therapeutics Development Initiative
11. Infant Formula Manufacturers Again under Ethical Cloud: Marketing Gimmick Linked to Serious Illnesses
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/16/2009)... Dec. 16 BioSpecifics Technologies Corp. (Nasdaq: ... in class collagenase-based products, today announced top-line efficacy ... trial of XIAFLEX(TM) for the treatment of Peyronie,s ... of inelastic collagen on the shaft of the ... sexual intercourse difficult or impossible in advanced cases. ...
(Date:12/16/2009)... -- MAQUET Cardiovascular LLC, a leading provider ... has signed a three-year single source provider ... contracting company, for MAQUET,s market-leading VASOVIEW Endoscopic ... assist healthcare providers in obtaining veins for ... small incisions. This allows for faster healing, ...
(Date:12/16/2009)... -- The Boards of Silence Therapeutics plc (AIM: ... the merger of their businesses to form a ... interference). The enlarged company, to be called ... and delivery technologies, a broad internal and partnered ... property. ,, The Directors believe the merger ...
Breaking Medicine Technology:BioSpecifics Technologies Corp. Announces Top-Line Phase 2b Results for XIAFLEX(TM) for Treatment of Peyronie's Disease 2BioSpecifics Technologies Corp. Announces Top-Line Phase 2b Results for XIAFLEX(TM) for Treatment of Peyronie's Disease 3BioSpecifics Technologies Corp. Announces Top-Line Phase 2b Results for XIAFLEX(TM) for Treatment of Peyronie's Disease 4MAQUET Cardiovascular Awarded Three-Year Single Source Contract From Novation for VASOVIEW Endoscopic Vessel Harvesting Devices 2MAQUET Cardiovascular Awarded Three-Year Single Source Contract From Novation for VASOVIEW Endoscopic Vessel Harvesting Devices 3MAQUET Cardiovascular Awarded Three-Year Single Source Contract From Novation for VASOVIEW Endoscopic Vessel Harvesting Devices 4Silence Therapeutics to Merge with Intradigm Corp to Create Leading RNAi Therapeutics Company 2Silence Therapeutics to Merge with Intradigm Corp to Create Leading RNAi Therapeutics Company 3Silence Therapeutics to Merge with Intradigm Corp to Create Leading RNAi Therapeutics Company 4Silence Therapeutics to Merge with Intradigm Corp to Create Leading RNAi Therapeutics Company 5Silence Therapeutics to Merge with Intradigm Corp to Create Leading RNAi Therapeutics Company 6CuraGen Updates CR011 vcMMAE Data at ASCO 4512 1CuraGen Updates CR011 vcMMAE Data at ASCO 4512 2CuraGen Updates CR011 vcMMAE Data at ASCO 4512 3CuraGen Updates CR011 vcMMAE Data at ASCO 4512 4CuraGen Updates CR011 vcMMAE Data at ASCO 4512 5CuraGen Updates CR011 vcMMAE Data at ASCO 4512 6CuraGen Updates CR011 vcMMAE Data at ASCO 4512 7Abbott 26 BioGenex Extend the Technology Co development and Distribution Agreement for Marketing the Xmatrx 28R 29 Advanced Staining Platform for the 12406 1Abbott 26 BioGenex Extend the Technology Co development and Distribution Agreement for Marketing the Xmatrx 28R 29 Advanced Staining Platform for the 12406 2The Killing of George Tiller 3A Video 26quot 3BThine Eyes 26quot 3B Shows True Face of Pro life Movement in the Face of 26apos 3BTerrorist 26apos 3 47577 1The Killing of George Tiller 3A Video 26quot 3BThine Eyes 26quot 3B Shows True Face of Pro life Movement in the Face of 26apos 3BTerrorist 26apos 3 47577 2
... alfa-2b) dosed every two weeks met the primary ... peginterferon alfa-2a dosed weekly in patients with genotype ... 900-mcg Albuferon had comparable rates of serious and/or ... of global marketing applications planned in fall 2009 ...
... 6 The American Medical Association (AMA) Foundation announced today the 28 ... the program provides $2,500 grants to medical students, physician residents and fellows ... award winners are conducting research in the following four categories: , ... Cardiovascular/pulmonary diseases , HIV/AIDS , ...
Other Medicine Technology:Human Genome Sciences Announces Positive Results in Second of Two Phase 3 Trials of Albuferon(R) in Chronic Hepatitis C 2Human Genome Sciences Announces Positive Results in Second of Two Phase 3 Trials of Albuferon(R) in Chronic Hepatitis C 3Human Genome Sciences Announces Positive Results in Second of Two Phase 3 Trials of Albuferon(R) in Chronic Hepatitis C 4Human Genome Sciences Announces Positive Results in Second of Two Phase 3 Trials of Albuferon(R) in Chronic Hepatitis C 5Human Genome Sciences Announces Positive Results in Second of Two Phase 3 Trials of Albuferon(R) in Chronic Hepatitis C 6Human Genome Sciences Announces Positive Results in Second of Two Phase 3 Trials of Albuferon(R) in Chronic Hepatitis C 7Human Genome Sciences Announces Positive Results in Second of Two Phase 3 Trials of Albuferon(R) in Chronic Hepatitis C 8Human Genome Sciences Announces Positive Results in Second of Two Phase 3 Trials of Albuferon(R) in Chronic Hepatitis C 9Human Genome Sciences Announces Positive Results in Second of Two Phase 3 Trials of Albuferon(R) in Chronic Hepatitis C 10AMA Foundation Announces Seed Grant Research Recipients 2AMA Foundation Announces Seed Grant Research Recipients 3
(Date:12/16/2009)... A diet rich in methionine, an amino acid ... garlic, lentils, onions, yogurt and seeds, can possibly ... to a study by Temple researchers. , The ... Amyloid-β formation and deposition in a mouse model ... Alzheimer Research . , "When methionine reaches too ...
(Date:12/16/2009)... employers strongly indicates that wellness programs have a positive impact ... ... Minneapolis, MN (PRWEB) December 16, 2009 -- ... percent of employers have improved employee participation in health and ... the survey, conducted by Hallmark Insights, a leader in incentive-driven ...
(Date:12/16/2009)... is honored to announce that Chris Wepfer and Jackie Kirby ... in Healthcare Traveler magazine’s 2009 Recruiters of the Year Showcase. ... such honors and the first for Jackie. , ... ... a national healthcare staffing agency, is honored to announce that ...
(Date:12/16/2009)... 16 Tyco International Ltd. (NYSE: ... Michael E. Daniels for election to the Tyco ... Meeting on March 10, 2010. ,, Daniels, ... Technology Services group of International Business Machines Corporation. ... IBM,s Global Services business operations consisting of outsourcing ...
(Date:12/16/2009)... Dec. 16 Sermo ( http://www.sermo.com ), ... announced the results of a new Sermo Vitals ... ." The report examines physician dialog about ... complete analysis of a variety of topics, including ... they prefer, and candid/verbatim comments on issues related ...
Breaking Medicine News(10 mins):Health News:Diet high in methionine could increase risk of Alzheimer's 2Health News:Hallmark Insights' Employer Survey Reveals Cost-Savings Benefits of Health & Wellness Programs 2Health News:Medical Solutions is Proud to Announce Chris Wepfer and Jackie Kirby as the Company's Recruiter of the Year Recipients 2Health News:Medical Solutions is Proud to Announce Chris Wepfer and Jackie Kirby as the Company's Recruiter of the Year Recipients 3Health News:Tyco International Files Preliminary Proxy Proposing Election of New Director 2Health News:Sermo Vitals Report(TM) Quantifies One Year of Physician Conversation About Diabetes 2Health News:Sermo Vitals Report(TM) Quantifies One Year of Physician Conversation About Diabetes 3
... Calif., May 12 Medical Care Corporation (MCC), ... technology, announced today that physicians now have a ... Screen, which enables them to accurately separate normal ... of memory loss associated with an underlying medical ...
... Call to Action demonstrates commitment to combating a leading ... and WaterAid America released two new reports today that ... are not responding to clear evidence on child mortality ... Diarrheal disease, a leading killer of children under age ...
... the skin , , TUESDAY, May 12 (HealthDay News) -- Any ... eased chronic lower back pain in a group of adult ... Cherkin, lead author of a report published in the May ... "Acupuncture is an effective treatment for chronic back pain. People ...
... Week 2009 -CAMBRIDGE, Mass. and NEW YORK, May 12, ... (NYSE: FRX ) today announced they will ... studies for linaclotide, a first-in-class investigational compound for the ... chronic constipation (CC), during the 2009 Digestive Disease Week ...
... 12 Last month The National Alliance of Advocates for ... patients seeking treatment for painkiller or heroin addiction compared to ... track for an astounding 200% gain. Dr. Michael Stein, author ... Oprah Magazine and The New York Times , tells ...
... MOUNTAIN VIEW, Calif., May 12 Based on ... market, Frost & Sullivan recognizes Sypris Test & ... & Sullivan Customer Service Leadership Award. This ... constant innovations, and strategic partnerships that have given ...
Other Medicine News:Health News:Medical Care Corporation Enables Early Detection of Memory Loss Due to Alzheimer's Disease 2Health News:Two New Reports Highlight Stalled Progress Against Diarrheal Disease: Nearly 1.6 Million Children Die Each Year From These Preventable and Treatable Diseases 2Health News:Two New Reports Highlight Stalled Progress Against Diarrheal Disease: Nearly 1.6 Million Children Die Each Year From These Preventable and Treatable Diseases 3Health News:Two New Reports Highlight Stalled Progress Against Diarrheal Disease: Nearly 1.6 Million Children Die Each Year From These Preventable and Treatable Diseases 4Health News:Acupuncture, Real or Fake, Eases Back Pain 2Health News:Acupuncture, Real or Fake, Eases Back Pain 3Health News:Ironwood and Forest to Present Additional Phase 2b Data for Novel Gastrointestinal Agent Linaclotide 2Health News:Ironwood and Forest to Present Additional Phase 2b Data for Novel Gastrointestinal Agent Linaclotide 3Health News:Ironwood and Forest to Present Additional Phase 2b Data for Novel Gastrointestinal Agent Linaclotide 4Health News:Economy Impacts People Seeking Treatment for Addiction - 80% Increase Over Last Year 2Health News:Economy Impacts People Seeking Treatment for Addiction - 80% Increase Over Last Year 3Health News:Frost & Sullivan Acknowledges Sypris for High-Quality Calibration Solutions 2Health News:Frost & Sullivan Acknowledges Sypris for High-Quality Calibration Solutions 3Health News:Frost & Sullivan Acknowledges Sypris for High-Quality Calibration Solutions 4
QualCraft™ Euro Lite has a molded nylon frame that fits most faces. Universal keyhole nose bridge fits narrow to average noses. Available with or without lead vinyl-lined side shields....
QualCraft™ Radiation-Reducing Eyewear is 50% lighter than other protective eyewear. Manufactured for the ultimate combination of comfort, function, and protection....
Clip-On Glasses clip onto regular eyewear frames. Plano (nonprescription) only. Will not fit over high-plus or high-minus presciptions, or over glasses with thick frames. Black wire frames. Wt. 63 g....
Portable shields for your safety and convenience....
Medicine Products: